Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 349, 109641
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic isletsBMC Medical Genetics, 2013
- Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancerBMC Cancer, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinomaBMC Cancer, 2009
- In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitroNature Protocols, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Cell adhesion and signalling by cadherins and Ig-CAMs in cancerNature Reviews Cancer, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences of the United States of America, 2003
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987